QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, July 22, 2009, 29(29):9344-9350; doi:10.1523/JNEUROSCI.1902-09.2009

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Taqatqeh, F. Articles by Mittmann, T. PubMed PubMed Citation Articles by Taqatqeh, F. Articles by Mittmann, T.

 Previous Article  |  Next Article 

Cellular/Molecular
More than a Retrograde Messenger: Nitric Oxide Needs Two cGMP Pathways to Induce Hippocampal Long-Term Potentiation

Feras Taqatqeh,^1 * Evanthia Mergia,^2 * Angela Neitz,¹ Ulf T. Eysel,¹ Doris Koesling,² and Thomas Mittmann¹

Departments of ¹Neurophysiology and ²Pharmacology and Toxicology, Medical School, Ruhr-University Bochum, 44780 Bochum, Germany

Correspondence should be addressed to Doris Koesling, Department of Pharmacology and Toxicology, Medical School, Ruhr-University Bochum, 44780 Bochum, Germany. Email: doris.koesling{at}ruhr-uni-bochum.de

Although nitric oxide (NO) has been implicated as a messenger molecule in hippocampal long-term potentiation (LTP) for almost 20 years, its precise function has not been elucidated because presynaptic and/or postsynaptic actions of NO have been reported. Most of the effects of NO as a signaling molecule are mediated by the NO receptor guanylyl cyclases (NO-GCs), two heme-containing enzymes with pronounced homology in which cGMP-forming activity is stimulated on NO binding. Here we report on knock-out (KO) mice in which either one of the NO-GC receptors has been genetically deleted. By measuring NO-induced cGMP levels, similar quantities of both NO-GC receptors were determined in the hippocampus. Surprisingly, hippocampal LTP was abolished in either one of the KO strains, demonstrating that both NO-GC receptors are required in the course of LTP. Expression of LTP was restored with a cGMP analog in one of the KO strains but did not recover in the other one. Moreover, single-cell recordings of paired pulse facilitation revealed a presynaptic role of one of the NO-GC isoforms in neurotransmitter release, confirming different roles of the NO-GC receptors in LTP. Because neither one of the NO/cGMP-induced responses by itself is sufficient for LTP, two divergent, possibly presynaptically and postsynaptically localized NO-stimulated cGMP pathways are apparently required for the expression of LTP. The unexpected role of cGMP at two sites of the synaptic cleft explains many of the controversial results in former NO research in LTP and demonstrates the necessity of presynaptic and postsynaptic changes for LTP expression.

---

Received April 22, 2009; revised June 15, 2009; accepted June 17, 2009.

Correspondence should be addressed to Doris Koesling, Department of Pharmacology and Toxicology, Medical School, Ruhr-University Bochum, 44780 Bochum, Germany. Email: doris.koesling{at}ruhr-uni-bochum.de

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help